OPKO Health (OPK) Misses Q2 EPS by 8c
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.45 +1.40%
EPS Growth %: +63.2%
Financial Fact:
Net loss attributable to common Shareholders: -14.98M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +63.2%
Financial Fact:
Net loss attributable to common Shareholders: -14.98M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q2 EPS of ($0.19), $0.08 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $156.8 million versus the consensus estimate of $165.7 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Senate votes to halt Iran war unless Trump gets approval from Congress
- Coherus and Zumutor to run Phase 1 trial combining ZM008 and Loqtorzi
- Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
